We are live on ! Find out more
GRCE icon

Grace Therapeutics

26 hedge funds and large institutions have $602K invested in Grace Therapeutics in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

4.12% less ownership

Funds ownership: 6.01% → 1.89% (-4.1%)

21% less funds holding

Funds holding: 33 → 26 (-7)

58% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 12

97% less capital inflows, than outflows

Capital inflows: $223K | Capital outflows: $8.4M

Holders
26
Holders Change
-7
Holders Change %
-21.21%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
6
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

GRCE Hedge Fund Activity: Q1 2020 in Review

26 of the 4,550 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q1 2020, worth a combined $602K — down 95% from $12.6M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of GRCE and 5 opened new positions — a net loss of 7 holders — while 6 trimmed existing stakes and 8 added.

The largest buyer was Oppenheimer & Co, adding an estimated $91.4K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $4.36M sold.

  • 26 institutional investors held Grace Therapeutics (GRCE) as of Q1 2020, down from 33 in Q4 2019.
  • Funds reported $602K of Grace Therapeutics stock for Q1 2020, down 95% quarter-over-quarter.
  • 5 funds opened new Grace Therapeutics positions in Q1 2020 and 12 closed out, a net change of -7 holders.
  • The largest Grace Therapeutics buyer in Q1 2020 was Oppenheimer & Co, an estimated $91.4K added.
  • The largest Grace Therapeutics seller in Q1 2020 was Perceptive Advisors, an estimated $4.36M sold.

Based on aggregated 13F filings for Q1 2020.